SIGNAL DETECTION

Disproportionality analysis: fast, but fragile, and easy to misuse

Disproportionality analysis is pharmacovigilance’s signal-detection workhorse. But more reports do not mean better evidence, and crude results can mislead.

05 February 2026

The ABCs of pharmacovigilance: Egypt’s signal management approach in action

Egypt's swift detection of vincristine-associated necrotising infections demonstrates how effective pharmacovigilance can identify risks and protect patients globally.

08 May 2025

How VigiFlow is helping to keep the wheel of pharmacovigilance turning in South Africa

South Africa’s pharmacovigilance system has been evolving for over a decade with UMC’s data management system supporting them every step of the way.

02 September 2024

Safety monitoring of orphan drugs: The SFDA experience

The safety of orphan drugs is hard to monitor as they target rare diseases afflicting small patient populations. However, an initiative led by the SFDA aims to improve this.

12 August 2024